Jonathan R Iredell (Jonathan Iredell)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Topics

Pseudomonas Aeruginosa

Infectious Diseases

Top Venues

Infection & chemotherapy

Nature microbiology

EMBO molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jonathan R Iredell, Holly Sinclair, Ameneh Khatami
Personalized bacteriophage therapy for difficult-to-treat infections. Nature microbiology 9 (6) (2024)
Jonathan R Iredell, Holly Sinclair, Ameneh Khatami
Personalized bacteriophage therapy for difficult-to-treat infections. Nature microbiology (2024)
Shinwon Lee, Stephanie Lynch, Ruby C Y Lin, Heejoon Myung, Jonathan R Iredell
Phage Therapy in Korea: A Prescribers' Survey of Attitudes Amongst Korean Infectious Diseases Specialists Towards Phage Therapy. Infection & chemotherapy 56 (1) (2023)
Shinwon Lee, Stephanie Lynch, Ruby C Y Lin, Heejoon Myung, Jonathan R Iredell
Phage Therapy in Korea: A Prescribers' Survey of Attitudes Amongst Korean Infectious Diseases Specialists Towards Phage Therapy. Infection & chemotherapy 56 (1) (2023)
Shinwon Lee, Stephanie Lynch, Ruby C Y Lin, Heejoon Myung, Jonathan R Iredell
Phage Therapy in Korea: A Prescribers' Survey of Attitudes Amongst Korean Infectious Diseases Specialists Towards Phage Therapy. Infection & chemotherapy 56 (1) (2023)
Shinwon Lee, Stephanie Lynch, Ruby C Y Lin, Heejoon Myung, Jonathan R Iredell
Phage Therapy in Korea: A Prescribers' Survey of Attitudes Amongst Korean Infectious Diseases Specialists Towards Phage Therapy. Infection & chemotherapy (2023)
Shinwon Lee, Stephanie Lynch, Ruby C Y Lin, Heejoon Myung, Jonathan R Iredell
Phage Therapy in Korea: A Prescribers' Survey of Attitudes Amongst Korean Infectious Diseases Specialists Towards Phage Therapy. Infection & chemotherapy 56 (1) (2023)
Shinwon Lee, Stephanie Lynch, Ruby C Y Lin, Heejoon Myung, Jonathan R Iredell
Phage Therapy in Korea: A Prescribers' Survey of Attitudes Amongst Korean Infectious Diseases Specialists Towards Phage Therapy. Infection & chemotherapy 56 (1) (2023)
Carola Venturini, Aleksandra Petrović Fabijan, Alicia Fajardo Lubian, Stefanie Barbirz, Jonathan R Iredell
Biological foundations of successful bacteriophage therapy. EMBO molecular medicine 14 (7) (2022)
Ameneh Khatami, Ruby C Y Lin, Aleksandra Petrović Fabijan, Sivan Alkalay-Oren, Sulaiman Almuzam, Philip N Britton, Michael J Brownstein, Quang Dao, Joe Fackler, Ronen Hazan, Bri'Anna Horne, Ran Nir-Paz, Jonathan R Iredell
Bacterial lysis, autophagy and innate immune responses during adjunctive phage therapy in a child. EMBO molecular medicine 13 (9) (2021)
Aleksandra Petrović Fabijan, Ruby C Y Lin, Josephine Ho, Susan Maddocks, Nouri L Ben Zakour, Jonathan R Iredell, null null
Safety of bacteriophage therapy in severe Staphylococcus aureus infection. Nature microbiology 5 (3) (2020)
Alicia Fajardo-Lubián, Nouri L Ben Zakour, Alex Agyekum, Qin Qi, Jonathan R Iredell
Host adaptation and convergent evolution increases antibiotic resistance without loss of virulence in a major human pathogen. PLoS pathogens 15 (3) (2019)
Muhammad Kamruzzaman, Shereen Shoma, Christopher M Thomas, Sally R Partridge, Jonathan R Iredell
Plasmid interference for curing antibiotic resistance plasmids in vivo. PloS one 12 (2) (2017)